Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
TNG, NitroStat, isosorbine dinitrate
|
nitroglycerin
|
|
Pharmacologic class of nitroglycerin
|
organic nitrate
|
|
Therapeutic class of nitroglycerin
|
antianginal, vasodilator, venodilator
|
|
Pharmacodynamics of nitroglycerin
|
reacts directly with nitrate receptor on SM cell
sulfhydryl groups in or on receptor reduce organic nitrate (R-NO3) to NO2 and then NO NO crosses into SM cells and activates guanylate cyclase leading to production of cGMP from GTP cGMP acits to relax SM cells (probably by dephosphorylation of myosin light chains, making them less likely to react with Actin) then produces venodilation and vasodilation |
|
cGMP with regards to NO
|
NO activates guanylate cyclase which produces cGMP from ATP
cGMP acts to relax SM cells (probably by dephosphorylation of myosin light chains, making them less likely to react with actin) |
|
Pharmacokinetics of nitroglycerin
|
well absorbed by mouth, BUUUT very high first pass effect
prompt onset (1-2 minutes) when taken as a SL tablet or spray can also be given transdermally or iv |
|
Toxicity of Nitroglycerin
|
excessive hypotension, especially if the patient is volume depleted
throbbing headache, flushing |
|
Interactions of Nitroglycerin with other drugs
|
excessive hypotension with other vasodilators
severe hypotension if taken with Viagra (sildenafil) |
|
Special considerations of Nitroglycerin
|
remove transdermal patch BEFORE defibrillation
use only fresh TNG tablets tolerance can develop quickly (give 8 hrs holiday qday...never take for 24 hours straight) Tachyphylaxis (less response after repeated dose) Take when sitting down, not driving (may get syncopic) Angina goes away in several minutes by reducing preload and lowering afterload by decreasing BP...increased perfusion by coronary arteries by vasodilation of the coronaries |
|
atenolol is a longer acting beta blocker
|
atenolol is a longer acting beta blocker
|
|
what should i NEVER do with beta blockers??
|
never withdrawal beta-blockers abruptly!!!
the abrupt increase in HR, BP, contractility, etc, can lead to abrupt increase in angina or even MI...REBOUND |
|
Tenormin, propranolol, metoprolol
|
same class as Atenolol
|
|
Pharmacologic class of Atenolol (propranolol, metoprolol)
|
beta adrenoceptor blocker
beta 1 specific |
|
Therapeutic class of Atenolol
|
antihypertensive, antiarrhythmic, primary and secondary prevention of MI, anti-anginal
|
|
Pharmacodynamics of Atenolol
|
binds directly to beta-receptors, with a preference for beta-1 over beta-2
leads to lower BP via several potential mechanisms (less CO, less activation of RAA system) |
|
Pharmacokinetics of Atenolol
|
available po or iv
variable oral F onset 1-2 hours duration: 12-24 hours can be given once pre day renally excreted (longer half-life) |
|
Toxicity of Atenolol
|
excessive hypotension
bradycardia heart block can worsen severe CHF (but indicated for mild to moderate CHF) worsen bronchospasm in severe asthmatics |
|
Interactions of atenolol with other drugs
|
additive effects with most other antihypertensives
additive AV block with CEB's |
|
Special considerations for atenolol
|
may be especially useful in HTN patients with exertional angina, MI, atrial fibrillation
watch out for abrupt withdrawal its generic, so its cheaper |
|
Verapamil
|
Isoptin, Calan, similar to nifedipine, amlodipine, and diliazem
|
|
Pharmacologic class of Verapamil
|
calcium entry blocker
|
|
Therapeutic class of Verapamil
|
antihypertensive, antianginal, and antiarrythmic
|
|
Pharmacodynamics of verapamil
|
reduces BP by inhibiting the influx of calcium through "slow channels"
thereby dilating peripheral arterioles produces negative inotropic effects as well for angina: reduces afterload, thus decreasing oxygen consumption inhibits spasm of coronary arteries in vasospastic angina blocks re-entry paths through AV node in paroxysmal SVT |
|
Pharmacokinetics of verapamil
|
absorbed rapidly, but F = 30%
available in SR tablets cleared by kidney and liver (produces active metabolites) onset 2 hours po 1-5 minutes iv half life is 6-12 hours |
|
Toxicity of verapamil
|
hypotension, AV block, worsening of CHF, and bradycardia
|
|
Interactions with other drugs and verapamil
|
additive effects with most other antihypertensives
additivie toxic effects on heart when given with beta-blockers |
|
Special considerations of verapamil
|
used reduced doses in patients with both renal and hepatic disease
short acting nifedipine (and similar CEB's) can increase risk of MI (unclear why) pregnancy C |
|
For vasospastic angina
|
whether spontaneous or induced, can be dramatically reversed by intracoronary nitroglycerin (observed in cath lab)
BETA BLOCKERS ARE CONTRAINDICATED!!! (because if you give beta-blockers, alpha 1 vasoconstriction will be left unopposed...make it worse) Use CEB's because of their direct vasodilating action |
|
What is vasospastic angina
|
primarily caused by sudden vasospasm of a major coronary artery (which may also be involved with atherosclerosis)
may also be related (or induced) by catecholamines, etc. |
|
Do NOT use beta blockers for what?
|
vasospastic angina
|
|
Unstable angina
|
this is a crescendo angina, preinfarction angina...all phrases that describe angina that is rapidly worsening in terms on intensity of pain, frequency, timing, trigger, duration, response to treatment, etc
most often involves a chronically narrowed artery WITH THE ACUTE DEVELOPMENT OF A RUPTURED PLAQUE must treat with suppression of platelet adhesion and aggregation |
|
Aspirin
(other names) |
Bayer, Acriptin, Halfprin, many others
|
|
Pharm class of Aspirin
|
salicylate
|
|
Therapeutic class of Aspirin
|
analgesic, anti-inflammatory, antiplatelet, antipyretic
|
|
Pharmacodynamics of Aspirin
|
at low doses (below 325 mg/day) tends to irreversibly inhibit COX in platelets, leading to decreased formation of thromboxane A2 (vasoconstrictor and platelet aggregator) and transiently inhibits COX in endothelium, leading to transient decreased formation of prostacyclin (PGI2...vasodilator, inhibitor of platelet aggregation)
|
|
Thromboxane A2
|
vasoconstrictor, platelet aggregator
|
|
Prostacyclin
(PGI2) |
vasodilator
inhibitor of platelet aggregation |
|
Pharmacokinetics of Aspirin
|
F = 60%
T max is variable Metabolized to salicylate half life 3-4 hours duration 4-24 hours 90% excreted as salicylate metabolites in urine |
|
Toxicity of aspirin
|
especially at high doses can cause ulceration of GI tract, bleeding disorders, and tinnitus
|
|
Interactions of aspirin with other drugs
|
inhibits tubular secretion of methotrexate, potentiate bleeding from warfarin
|
|
Special considerations of Aspirin
|
avoid in patients with nasal polyps and asthma
regular, buffered, enteric coated |
|
COX 2 inhibitors
|
selectively inhibits the production of PGI2 (which we said was a vasodilator, inhibitor of platelet aggregation)
this causes worse platelet aggregation patients had excess strokes and heart attacks |
|
Clopidogrel
(common name) |
Plavix
|
|
Therapeutic class of clopidogrel
|
platelet aggregation inhibitor
|
|
Pharmacodynamics of Clopidogrel
|
blocks ADP receptors, which then helps prevent aggregation mediated by ADP released by an activated platelet from recruiting other platelets
useful in primary or secondary prevention of TIA, stroke, angina, MI, PCTA, ACS, stent procedures, etc. |
|
Pharmacokinetics of Clopidogrel
|
well absorbed
onset 1-2 hours after oral dose hepatic metabolism half life -8 hours |
|
Toxicity of Clopidogrel
|
hemorrhage at virtually any site
|
|
Interactions of Clopidogrel with other drugs
|
may inhibit CYP 3A4
|
|
Special considerations of Clopidogrel
|
careful risk/benefit assessment in each patient
ITS QUITE EXPENSIVE |
|
Abciximab
(other names) |
ReoPro
Tirofiban/Aggrastat Eptifibatide/Integrilin |
|
Pharm class of abciximab
|
Fab fragment chimeric monoclonal antibody
|
|
Therapeutic class of abciximab
|
adjuct to PCL to prevent ischemic complications
Treatment of MI |
|
Pharmacodynamics of Abciximab
|
noncompetitive inhibitor of the GP IIb/IIIa receptor
prevents binding of fibrinogen, vWF, and other adhesive ligands to the receptor on activated platelets need to block > 80% of these receptors to maximally inhibit platelet |
|
Pharmacokinetics of Abciximab
|
IV bolus followed by IV infusion
half life about 30 minutes bleeding time declines to <12 minutes with 12 hours of stopping infusion |
|
Toxicity of Abciximab
|
contraindicated in presence of aneurysm, AV malformation, bleeding, coagulopathy, GI bleed, intracranial mass, retinal bleeding, stroke, surgery, low platelet, trauma, and fasculitis
|
|
Interactions of Abciximab
|
additive effects with aspirin, clopidogrel heparin, low dose t-PA
|
|
Special considerations of Abciximab
|
exact role is still being defined, and evolves over time
cost is a big factor |
|
More about NO...its an EDRF
|
endothelium derived relaxing factor
|
|
Produce NO directly
|
NO and nitroprusside
|
|
Drugs that encourage the production of NO from endothelial cells
|
Acetylcholine, histamine, bradykinin, serotonin, substance P
|
|
Other effects of NO
|
inhibition of platelet aggregation, phagocytosis, excitatory neurotransmission in CNS
|
|
Propranolol is NOT
|
cardioselective
Thus, other beta-blockers like metoprolol, acebutolol, or atenolol are preferred important for asthmatics |
|
Pindolol has...
|
intrinsic sympathomimetic activity
less effective in anti-angina endeavors and should be avoided |
|
Beta blockers have been shown to...
|
prolong survival
|
|
Beta blockers are contraindicated in...
|
patients with asthma, diabetes, severe bradycardia, peripheral vascular disease, or COPD
|
|
Make sure to do what with Beta blockers??
|
do NOT discontinue abruptly
gradual tapering of the dose over 5-10 days to avoid rebound angina or hypertension |
|
Calcium channel blockers
|
decrease the inward current carried by calcium, resulting in a decreased rate of Phase 4 spontaneous depolarization
slow conduction in tissues that are dependent on calcium currents, such as the AV node MAJOR EFFECT IS ON VASCULAR SM AND THE HEART all calcium channel blockers are therefore vasodilators that cause a decrease in SM tone and vascular resistance used for vasospastic angina: NOT beta blockers (because if beta blockers were used, alpha 1 vasoconstriction would go about unopposed) |
|
Verpamil mainly affects:
Nifidepine mainly affects: Diltiazem mainly affects: |
Verapamil: myocardium (greater inotropic decreasing effects, but worse vasodilator..greatly metabolized in the liver)
Nifedipine: more effect of SM in peripheral vasculature Diltiazem: somewhere in between; cardio effects similar to diltiazem, but not as potent...can releive coronary artery spasm...extensively metabolized in the liver) |